<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T06:51:52Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2445/138563" metadataPrefix="mets">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2445/138563</identifier><datestamp>2025-12-04T22:54:57Z</datestamp><setSpec>com_2072_1057</setSpec><setSpec>col_2072_478781</setSpec><setSpec>col_2072_478782</setSpec><setSpec>col_2072_478917</setSpec></header><metadata><mets xmlns="http://www.loc.gov/METS/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" ID="&#xa;&#x9;&#x9;&#x9;&#x9;DSpace_ITEM_2445-138563" TYPE="DSpace ITEM" PROFILE="DSpace METS SIP Profile 1.0" xsi:schemaLocation="http://www.loc.gov/METS/ http://www.loc.gov/standards/mets/mets.xsd" OBJID="&#xa;&#x9;&#x9;&#x9;&#x9;hdl:2445/138563">
   <metsHdr CREATEDATE="2026-04-17T08:51:52Z">
      <agent ROLE="CUSTODIAN" TYPE="ORGANIZATION">
         <name>RECERCAT</name>
      </agent>
   </metsHdr>
   <dmdSec ID="DMD_2445_138563">
      <mdWrap MDTYPE="MODS">
         <xmlData xmlns:mods="http://www.loc.gov/mods/v3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
            <mods:mods xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Navarro Brugal, Gemma</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Franco, Nuria</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Martínez-Pinilla, Eva</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Franco Fernández, Rafael</mods:namePart>
               </mods:name>
               <mods:originInfo>
                  <mods:dateIssued encoding="iso8601">2019-07-30T09:36:01Z2019-07-30T09:36:01Z2017-11-282019-07-30T09:36:01Z</mods:dateIssued>
               </mods:originInfo>
               <mods:identifier type="none"/>
               <mods:abstract>A single word, Epigenetics, underlies one exciting subject in today's Science, with different sides and with interactions with philosophy. The apparent trivial description includes everything in between genotype and phenotype that occurs for a given unique DNA sequence/genome. This Perspective article first presents an historical overview and the reasons for the lack of consensus in the field, which derives from different interpretations of the diverse operative definitions of Epigenetics. In an attempt to reconcile the different views, we propose a novel concept, the "cytocrin system." Secondly, the article questions the inheritability requirement and makes emphasis in the epigenetic mechanisms, known or to be discovered, that provide hope for combating human diseases. Hopes in cancer are at present in deep need of deciphering mechanisms to support ad hoc therapeutic approaches. Better perspectives are for diseases of the central nervous system, in particular to combat neurodegeneration and/or cognitive deficits in Alzheimer's disease. Neurons are post-mitotic cells and, therefore, epigenetic targets to prevent neurodegeneration should operate in non-dividing diseased cells. Accordingly, epigenetic-based human therapy may not need to count much on transmissible potential. Keywords: nucleocrin, thermodynamics, state variables, inheritability, therapy, Alzheimer's disease, cancer, tumor therapy</mods:abstract>
               <mods:language>
                  <mods:languageTerm authority="rfc3066"/>
               </mods:language>
               <mods:accessCondition type="useAndReproduction">cc-by (c) Navarro Brugal, Gemma et al., 2017 http://creativecommons.org/licenses/by/3.0/es info:eu-repo/semantics/openAccess</mods:accessCondition>
               <mods:subject>
                  <mods:topic>Epigenètica</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Expressió gènica</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Genètica bioquímica</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Epigenetics</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Gene expression</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Biochemical genetics</mods:topic>
               </mods:subject>
               <mods:titleInfo>
                  <mods:title>The epigenetic Cytocrin pathway to the nucleus. Epigenetic factors, epigenetic mediators, and epigenetic traits. A biochemist perspective.</mods:title>
               </mods:titleInfo>
               <mods:genre>info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion</mods:genre>
            </mods:mods>
         </xmlData>
      </mdWrap>
   </dmdSec>
   <structMap LABEL="DSpace Object" TYPE="LOGICAL">
      <div TYPE="DSpace Object Contents" ADMID="DMD_2445_138563"/>
   </structMap>
</mets></metadata></record></GetRecord></OAI-PMH>